ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

LBPH Longboard Pharmaceuticals Inc

21,375
-1,44 (-6,29%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Longboard Pharmaceuticals Inc LBPH NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-1,44 -6,29% 21,375 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
23,50 21,07 23,955 21,375 22,81
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:01BWLongboard Pharmaceuticals Reports First Quarter 2024..
03/4/202415:00BWLongboard Pharmaceuticals to Present Late-Breaking Data from..
02/4/202422:00BWLongboard Pharmaceuticals Announces Inducement Grants Under..
12/3/202421:01BWLongboard Pharmaceuticals Reports Full Year 2023 Financial..
01/3/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
02/2/202422:30BWLongboard Pharmaceuticals Announces Inducement Grants Under..
01/2/202414:30BWLongboard Pharmaceuticals to Present at Two Upcoming..
08/1/202422:05BWLongboard Pharmaceuticals Announces Closing of Public..
04/1/202422:51EDGAR2Form 8-K - Current report
04/1/202422:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202403:40BWLongboard Pharmaceuticals Announces Pricing of Upsized..
04/1/202402:59EDGAR2Form S-3MEF - Registration adding securities to prior Form..
02/1/202422:54EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/1/202422:02EDGAR2Form 8-K - Current report
02/1/202422:01BWLongboard Pharmaceuticals Announces Commencement of Public..
02/1/202415:44EDGAR2Form 8-K - Current report
02/1/202414:00BWLongboard Pharmaceuticals Announces Positive Topline Data..
01/1/202422:47BWLongboard Pharmaceuticals to Host Call to Discuss Topline..
29/11/202314:35EDGAR2Form 8-K - Current report
29/11/202314:30BWLongboard Pharmaceuticals Announces Initiation of..
21/11/202322:00BWLongboard Pharmaceuticals’ Presence at American Epilepsy..
03/11/202321:01BWLongboard Pharmaceuticals Announces Inducement Grant Under..
02/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:05EDGAR2Form 8-K - Current report
02/11/202321:01BWLongboard Pharmaceuticals Provides Corporate Update and..
01/11/202313:30BWLongboard Pharmaceuticals to Present at Three Upcoming..
11/10/202315:26EDGAR2Form 8-K - Current report
05/10/202322:05BWLongboard Pharmaceuticals Announces Speakers for Investor &..
22/9/202322:21EDGAR2Form 8-K - Current report
19/9/202314:30BWLongboard Pharmaceuticals to Host Investor & Analyst Event..
31/8/202322:00BWLongboard Pharmaceuticals to Participate in Three Upcoming..
30/8/202322:01BWLongboard Pharmaceuticals to Present Data at Upcoming..
23/8/202314:46EDGAR2Form 8-K - Current report
23/8/202314:30BWLongboard Pharmaceuticals Completes Enrollment of Phase..
14/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
04/8/202323:00EDGAR2Form 8-K - Current report
04/8/202322:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/8/202322:10EDGAR2Form S-3 - Registration statement under Securities Act of..
03/8/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:12EDGAR2Form 8-K - Current report
03/8/202322:01BWLongboard Pharmaceuticals Provides Corporate Update and..
03/8/202314:30BWLongboard Pharmaceuticals to Present at Upcoming Investor..
26/6/202322:00BWLongboard Pharmaceuticals to Participate in Fireside Chat..
09/5/202322:00BWLongboard Pharmaceuticals Provides Corporate Update and..

Dernières Valeurs Consultées

Delayed Upgrade Clock